Anti-STON2 monoclonal antibody

Pre-made anti-STON2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STON2/STON2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1842-Ab-1/ GM-Tg-hg-IP1842-Ab-2Anti-Human STON2 monoclonal antibodyHuman
GM-Tg-rg-IP1842-Ab-1/ GM-Tg-rg-IP1842-Ab-2Anti-Rat STON2 monoclonal antibodyRat
GM-Tg-mg-IP1842-Ab-1/ GM-Tg-mg-IP1842-Ab-2Anti-Mouse STON2 monoclonal antibodyMouse
GM-Tg-cynog-IP1842-Ab-1/ GM-Tg-cynog-IP1842-Ab-2Anti-Cynomolgus/ Rhesus macaque STON2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1842-Ab-1/ GM-Tg-felg-IP1842-Ab-2Anti-Feline STON2 monoclonal antibodyFeline
GM-Tg-cang-IP1842-Ab-1/ GM-Tg-cang-IP1842-Ab-2Anti-Canine STON2 monoclonal antibodyCanine
GM-Tg-bovg-IP1842-Ab-1/ GM-Tg-bovg-IP1842-Ab-2Anti-Bovine STON2 monoclonal antibodyBovine
GM-Tg-equg-IP1842-Ab-1/ GM-Tg-equg-IP1842-Ab-2Anti-Equine STON2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1842-Ab-1/ GM-Tg-hg-IP1842-Ab-2; GM-Tg-rg-IP1842-Ab-1/ GM-Tg-rg-IP1842-Ab-2;
GM-Tg-mg-IP1842-Ab-1/ GM-Tg-mg-IP1842-Ab-2; GM-Tg-cynog-IP1842-Ab-1/ GM-Tg-cynog-IP1842-Ab-2;
GM-Tg-felg-IP1842-Ab-1/ GM-Tg-felg-IP1842-Ab-2; GM-Tg-cang-IP1842-Ab-1/ GM-Tg-cang-IP1842-Ab-2;
GM-Tg-bovg-IP1842-Ab-1/ GM-Tg-bovg-IP1842-Ab-2; GM-Tg-equg-IP1842-Ab-1/ GM-Tg-equg-IP1842-Ab-2
Products NameAnti-STON2 monoclonal antibody
Formatmab
Target NameSTON2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STON2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1842-Ag-1Recombinant multi-species STON2/ STN2/ STNB protein


    Target information

    Target IDGM-IP1842
    Target NameSTON2
    Gene ID85439,108800,314349,708331,490815,101088416,785664,100052660
    Gene Symbol and Synonyms4933401N24Rik,RGD1311502,STN2,STNB,STNB2,STON2
    Uniprot AccessionQ8WXE9,D4AB66
    Uniprot Entry NameSTON2_HUMAN,STON2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000140022
    Target ClassificationN/A

    The target: STON2, gene name: STON2, also named as STN2, STNB, STNB2. This gene encodes a protein which is a membrane protein involved in regulating endocytotic complexes. The protein product is described as one of the clathrin-associated sorting proteins, adaptor molecules which ensure specific proteins are internalized. The encoded protein has also been shown to participate in synaptic vesicle recycling through interaction with synaptotagmin 1 required for neurotransmission. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.